IL-2 therapy: potential impact of the CD4 cell count at initiation on clinical efficacy—results from the ANRS CO4 cohort
in Journal of Antimicrobial Chemotherapy
October 2010; p ublished online August 2010 .
Journal Article. Subjects: Medical Oncology; Critical Care. 5715 words.
We investigated why, despite its beneficial effect on the CD4 cell count, IL-2 therapy had no clinical benefit as shown in the ESPRIT and SILCAAT...